Journal of Medicinal Chemistry p. 11215 - 11234 (2020)
Update date:2022-08-23
Topics:
Hu, Liqing
Li, Lijun
Chang, Qi
Fu, Songsen
Qin, Jia
Chen, Zhuo
Li, Xiaohui
Liu, Qinglian
Hu, Gaoyun
Li, Qianbin
Current pulmonary arterial hypertension (PAH) therapeutic strategies mainly focus on vascular relaxation with less emphasis on vascular remodeling, which results in poor prognosis. Hence, dual pathway regulators with vasodilation effect via soluble guanylate cyclase (sGC) stimulation and vascular remodeling regulation effect by AMP-activated protein kinase (AMPK) inhibition provide more advantages and potentialities. Herein, we designed and synthesized a series of novel pyrazolo[3,4-b] pyridine derivatives based on sGC stimulator and AMPK inhibitor scaffolds. In vitro, 2 exhibited moderate vasodilation activity and higher proliferation and migration suppressive effects compared to riociguat. In vivo, 2 significantly decreased right ventricular systolic pressure (RVSP), attenuated pulmonary artery medial thickness (PAMT), and right ventricular hypertrophy (RVH) in hypoxia-induced PAH rat models (i.g.). Given the unique advantages of significant vascular remodeling inhibition and moderate vascular relaxation based on the dual pathway regulation, we proposed 2 as a promising lead for anti-PAH drug discovery.
View MoreNanJing Rate Biochemicals CO., LTD
Contact:+86-25-84931986
Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
suzhou BetterBioChem Co., Ltd.
website:http://www.betterbiochem.com
Contact:+86-18013506594
Address:No. 8 Building, 18 nong, Xi Yingnan Road, Pudong, Shanghai,China
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
Weihao Chemtech (ChangZhou) Co., Ltd.
Contact:051989185693
Address:NO 217 huangshan Rd ,Changzhou
Shijiazhuang Haitian Amino Acid Co., Ltd.
Contact:+86-311-88908111
Address:Shijiazhuang Hebei province,China
Doi:10.1016/0022-2852(86)90032-9
(1986)Doi:10.1016/j.tetlet.2005.03.052
(2005)Doi:10.1002/hlca.19930760107
(1993)Doi:10.1016/j.carres.2006.10.011
(2006)Doi:10.1002/(SICI)1099-1344(20000315)43:3<283::AID-JLCR314>3.0.CO;2-F
(2000)Doi:10.1021/ja00904a038
(1963)